Mag. Eva-Maria Klebermass



Lang, C, Klebermass, E-M, Balber, T, Hirtl, Y, klimpke, A, Sperr, E, Eder, P, Quint, R, Somloi, S, Hutz, J, Valaskova, P, Jasprová, J, Vítek, L & Wagner, K-H 2018, 'Targeting mechanisms to better understand the improved lipid and glucose status of mild hyperbilirubinemia, an in vitro approach' ÖGE Jahrestagung 2018, Wien, Österreich, 15/11/18 - 16/11/18, .

Lang, C, Klebermass, E-M, Balber, T, Hirtl, Y, Klimpke, A, Sperr, E, Eder, P, Quint, R, Somloi, S, Hutz, J, Valaskova, P, Jasprová, J, Vítek, L & Wagner, K-H 2018, 'Targeting mechanisms to better understand the improved lipid and glucose status of mild hyperbilirubinemia, an in vitro approach' 10th International Conference on Heme Oxygenase, Seoul, Südkorea, 31/10/18 - 3/11/18, .

Lang, C, Klebermass, E-M, Balber, T, Hirtl, Y, klimpke, A, Sperr, E, Eder, P, Jasprová, J, Vítek, L, Heiß, E & Wagner, K-H 2018, 'Targeting mechanisms to better understand the improved lipid and glucose status of mild hyperbilirubinemia, an in vitro approach' NuGOweek 2018, Newcastle upon Tyne, Großbritannien / Vereinigtes Königreich, 3/09/16 - 6/09/18, .

Bauer, M, Matsuda, A, Wulkersdorfer, B, Philippe, C, Traxl, A, O¨zvegy-Laczka, C, Stanek, J, Nics, L, Klebermass, EM, Poschner, S, Jäger, W, Patik, I, Bakos, E, Szakács, G, Wadsak, W, Hacker, M, Zeitlinger, M & Langer, O 2018, 'Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography', Clinical Pharmacology and Therapeutics, Jg. 104, Nr. 1, S. 139-147. https://doi.org/10.1002/cpt.888


Vraka, C, Mijailovic, S, Fröhlich, V, Zeilinger, M, Klebermass, E-M, Wadsak, W, Wagner, K-H, Hacker, M & Mitterhauser, M 2018, 'Expanding LogP: Present possibilities', Nuclear Medicine and Biology, Jg. 58, S. 20-32. https://doi.org/10.1016/j.nucmedbio.2017.11.007

Forschungsplattform Active Ageing

Althanstraße 14 (UZA II)
1090 Wien

eva-maria.klebermass@univie.ac.at